USPTO serial 76337267
PHARMALOGIC
Reviewed by CopyMark Law Group
Reg. 2666078Status 710
- Filing date
- Status date
- Registration date
- Dec 24, 2002
- Examiner
- CHARLON, BARNEY
- Law office
- GENERIC WEB UPDATE
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PHARMALOGIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Arlington, VA
Boca Raton, FL
Boca Raton, FL
Boca Raton, FL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bharati Bakshani
Bharati Bakshani LADAS & PARRY LLP1040 AVENUE OF THE AMERICASNEW YORK, NY 10018-3738UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Radioactive isotope labeled compounds for use in the study and visualization of human physiology for scientific and medical research use | SECTION 8 - CANCELLED | — |
| 005 | Radioactive isotope labeled compounds for use in the study and visualization of human physiology for medical diagnostic use | SECTION 8 - CANCELLED | — |
| 035 | Wholesale distributorship featuring patient specific intravenous drugs and solutions for use in diagnostic imaging, manufacturing and synthesizing of FDG (fluorodeoxyglucose) labeled with a radioactive isotope that enables a physician to study and visualize human physiology | SECTION 8 - CANCELLED | — |
| 040 | Manufacturing and synthesizing for others of patient specific intravenous drugs and solutions for use in diagnostic imaging; manufacturing and synthesizing of FDG [(flurodeoxyglucose)] * fluorodeoxyglucose * labeled with a radioactive isotope that enables a physician to study and visualize human physiology | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharmalogic Holdings Corp.
- Other trademarks owned by Chatoff Holdings, LLC
- Other trademarks owned by Chatoff Holdings, LLC
- Other trademarks owned by Chatoff Holdings, LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Similar marks named PHARMALOGIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 22, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jul 7, 2023 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Mar 15, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Dec 24, 2021 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Mar 24, 2021 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 9, 2015 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 8, 2015 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 19, 2012 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Nov 19, 2012 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Nov 19, 2012 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Nov 16, 2012 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 30, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 15, 2008 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 29, 2008 | PLGL | ASSIGNED TO PARALEGAL | — |
| Oct 27, 2008 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 27, 2008 | PAPER RECEIVED | — | |
| Jun 5, 2008 | CFIT | CASE FILE IN TICRS | — |
| Aug 2, 2006 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 28, 2003 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 8, 2003 | AMD7 | SEC 7 REQUEST FILED | — |
| May 8, 2003 | PAPER RECEIVED | — | |
| Dec 24, 2002 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 1, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 11, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 2, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2002 | PAPER RECEIVED | — | |
| Feb 11, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2002 | DOCK | ASSIGNED TO EXAMINER | — |